Understanding Your Child's Dravet Syndrome Diagnosis
At a Glance
Dravet syndrome is a rare, genetic epilepsy typically caused by an SCN1A mutation, leading to temperature-sensitive seizures. The most crucial first step for parents is consulting a pediatric epileptologist to access specialized treatments and avoid common medications that can worsen the condition.
If you are reading this, you are likely in the middle of a storm. Receiving a diagnosis of Dravet syndrome for your infant or toddler is often a moment of profound shock and exhaustion. You may have spent months or even years searching for answers while watching your child experience terrifying seizures. It is important to pause and acknowledge that what you are feeling—the fear, the overwhelm, and the grief—is a natural response to a complex diagnosis. You are not alone, and there is a path forward for you, your child, and your entire family.
Stabilizing Facts for Your Family
When everything feels like it is spinning out of control, these three facts can serve as an anchor:
- This is not your fault. Dravet syndrome is a genetic condition, often caused by a random (de novo) mutation in the SCN1A gene [1][2]. It was not caused by anything you did during pregnancy, any choice you made in parenting, or any environmental factor [1].
- The “old” rules don’t always apply. Dravet syndrome was formerly known as Severe Myoclonic Epilepsy of Infancy (SMEI) [3]. While it remains a serious condition, the medical community’s understanding has evolved rapidly. What you may read in older textbooks or outdated websites does not reflect the modern reality of care [4].
- Treatment has entered a new era. For a long time, doctors had very few tools to help. Today, there are several FDA-approved treatments specifically for Dravet syndrome, such as fenfluramine, cannabidiol, and stiripentol [5][6][7]. Research into gene therapies and disease-modifying treatments is also actively progressing [8].
What is Dravet Syndrome?
Dravet syndrome is a rare and severe form of epileptic encephalopathy—a term used when the underlying genetic mutation and seizure activity itself contribute to developmental delays [3]. It typically begins in the first year of life in a child who was previously developing as expected [3].
The hallmark of the condition is seizures that are highly sensitive to hyperthermia (an increase in body temperature) [3]. This doesn’t just mean high fevers; for a child with Dravet, even a warm bath, physical exertion, or a slight change in ambient temperature can trigger a seizure [3]. About 80% to 90% of children with this syndrome have a mutation in the SCN1A gene, which acts like a blueprint for a “gate” (the NaV1.1 sodium channel) that controls electrical signals in the brain [9][10]. When this gate doesn’t work correctly, the brain’s “brakes” (inhibitory neurons) fail, leading to uncontrolled electrical activity [9].
Why You Need a Pediatric Epileptologist
Because Dravet syndrome is rare and complex, a general neurologist may not have the specialized experience required to manage it safely. It is critical that your child is seen by a pediatric epileptologist—a pediatrician who has completed extra years of training specifically in childhood epilepsy.
- Avoid Harmful Medications: This is the most urgent reason to see a specialist. Many common “first-line” seizure medications are sodium channel blockers (like carbamazepine or lamotrigine) [11]. In most types of epilepsy, these help; however, in Dravet syndrome, they can actually make seizures worse or more frequent [11][12]. An expert will know which drugs to avoid immediately [13].
- Comprehensive Care: Modern management involves more than just stopping seizures. A specialist at a Level 3 or 4 Comprehensive Epilepsy Center coordinates a team to address the “whole child,” including motor skills, speech development, and behavioral health [14][4].
- Advanced Monitoring: Specialized centers have access to long-term video-EEG and advanced imaging that can help tailor a precise treatment plan [15][16]. Studies show that children treated at these specialized centers often have better long-term outcomes [17].
While the incidence of Dravet syndrome is rare, the community of families and specialists is deeply connected [18]. Finding the right team is the first and most important step in moving from a state of crisis to a state of management.
Common questions in this guide
What causes Dravet syndrome in children?
Why do baths or warm temperatures cause seizures in Dravet syndrome?
Why is it so important to see a pediatric epileptologist for Dravet syndrome?
Why do some seizure medications make Dravet syndrome worse?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Does our child have an SCN1A gene mutation, and how does that specific mutation affect our treatment plan?
- 2.Are any of our child's current medications 'sodium channel blockers' that could potentially make Dravet seizures worse?
- 3.How many children with Dravet syndrome have you personally treated in your career?
- 4.What is our specific 'rescue plan' for when a seizure lasts longer than five minutes?
- 5.Can you refer us to a Level 3 or 4 Comprehensive Epilepsy Center if this office doesn't have a pediatric epileptologist?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (18)
- 1
[Analysis of parental origin of de novo SCN1A mutations in Dravet syndrome].
Sun H, Zhang Y, Xu X, et al.
Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2015; (32(4)):457-61 doi:10.3760/cma.j.issn.1003-9406.2015.04.001.
PMID: 26252084 - 2
Development and Validation of a Prediction Model for Early Diagnosis of SCN1A-Related Epilepsies.
Brunklaus A, Pérez-Palma E, Ghanty I, et al.
Neurology 2022; (98(11)):e1163-e1174 doi:10.1212/WNL.0000000000200028.
PMID: 35074891 - 3
Dravet Syndrome: An Overview.
Anwar A, Saleem S, Patel UK, et al.
Cureus 2019; (11(6)):e5006 doi:10.7759/cureus.5006.
PMID: 31497436 - 4
Diagnosis, epilepsy treatment and supports for neurodevelopment in children with Dravet Syndrome: Caregiver reported experiences and needs.
Soto Jansson J, Bjurulf B, Dellenmark Blom M, et al.
Epilepsy & behavior : E&B 2024; (151()):109603 doi:10.1016/j.yebeh.2023.109603.
PMID: 38168600 - 5
Cardiovascular safety of fenfluramine in the treatment of Dravet syndrome: Analysis of an ongoing long-term open-label safety extension study.
Lai WW, Galer BS, Wong PC, et al.
Epilepsia 2020; (61(11)):2386-2395 doi:10.1111/epi.16638.
PMID: 32809271 - 6
Recent Advances in the Drug Treatment of Dravet Syndrome.
Wirrell EC, Nabbout R
CNS drugs 2019; (33(9)):867-881 doi:10.1007/s40263-019-00666-8.
PMID: 31549357 - 7
Efficacy and safety of stiripentol in the prevention and cessation of status epilepticus: A systematic review.
Specchio N, Auvin S, Strzelczyk A, et al.
Epilepsia open 2024; (9(6)):2017-2036 doi:10.1002/epi4.13036.
PMID: 39360600 - 8
Emerging Genetic Therapies in Epilepsy.
Sullivan J, Hood V
Seminars in neurology 2025; (45(2)):298-302 doi:10.1055/a-2544-1530.
PMID: 39993433 - 9
Cannabidiol attenuates seizures and social deficits in a mouse model of Dravet syndrome.
Kaplan JS, Stella N, Catterall WA, Westenbroek RE
Proceedings of the National Academy of Sciences of the United States of America 2017; (114(42)):11229-11234 doi:10.1073/pnas.1711351114.
PMID: 28973916 - 10
Mortality in Dravet syndrome.
Cooper MS, Mcintosh A, Crompton DE, et al.
Epilepsy research 2016; (128()):43-47 doi:10.1016/j.eplepsyres.2016.10.006.
PMID: 27810515 - 11
Dravet syndrome diagnosed in adults.
Dudley AM, Peña-Ceballos J, El-Naggar H, et al.
Practical neurology 2026; (26(2)):124-132 doi:10.1136/pn-2025-004743.
PMID: 41136202 - 12
Dravet Syndrome: Diagnosis and Long-Term Course.
Connolly MB
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 2016; (43 Suppl 3()):S3-8 doi:10.1017/cjn.2016.243.
PMID: 27264139 - 13
Cenobamate in pediatric epilepsy and developmental and epileptic encephalopathies: Efficacy, safety, and syndrome-specific considerations.
Samanta D
Epilepsy & behavior : E&B 2025; (173()):110787 doi:10.1016/j.yebeh.2025.110787.
PMID: 41106086 - 14
International consensus on the use of [18F]-FDG PET/CT in pediatric patients affected by epilepsy.
Tian M, Watanabe Y, Kang KW, et al.
European journal of nuclear medicine and molecular imaging 2021; (48(12)):3827-3834 doi:10.1007/s00259-021-05524-8.
PMID: 34453559 - 15
Determinants of successful ictal SPECT injection in phase 1 epilepsy presurgical evaluation: Findings from the pediatric epilepsy research consortium surgery database project.
Joshi C, Singh R, Liu G, et al.
Epilepsia open 2024; (9(4)):1467-1479 doi:10.1002/epi4.12986.
PMID: 38845472 - 16
Pediatric Epilepsy Management: Special Considerations.
Nickels K, Joshi C
Seminars in neurology 2025; (45(2)):189-197 doi:10.1055/a-2531-3610.
PMID: 39904397 - 17
Association of quality of paediatric epilepsy care with mortality and unplanned hospital admissions among children and young people with epilepsy in England: a national longitudinal data linkage study.
Hargreaves DS, Arora S, Viveiro C, et al.
The Lancet. Child & adolescent health 2019; (3(9)):627-635 doi:10.1016/S2352-4642(19)30201-9.
PMID: 31281027 - 18
A systematic literature review on the global epidemiology of Dravet syndrome and Lennox-Gastaut syndrome: Prevalence, incidence, diagnosis, and mortality.
Sullivan J, Benítez A, Roth J, et al.
Epilepsia 2024; (65(5)):1240-1263 doi:10.1111/epi.17866.
PMID: 38252068
This page provides educational information about Dravet syndrome for parents and caregivers. It does not replace professional medical advice, diagnosis, or treatment planning from your child's pediatric epileptologist.
Get notified when new evidence is published on Dravet syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.